Université Paris-Sud XI;ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS;Université Paris Descartes
发明人:
申请号：
EP10700864.1
公开号：
EP2379101B1
申请日:
2010.01.15
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention relates to the use of a composition including of at least a mutated antithrombin having an anticoagulant activity substantially reduced with respect to the anticoagulant activity of the non mutated antithrombin, or having no anticoagulant activity, for the preparation of a drug intended for the prevention or the treatment of pathologies associated with cellular injury, such as infection, inflammation or hypoxic injury.
